Global Cord Blood Corporation (CO) Stock Price & Overview

NYSE:CO • KYG393421030

Current stock price

2.9876 USD
+0.77 (+34.58%)
At close:
2.925 USD
-0.06 (-2.1%)
Pre-Market:

The current stock price of CO is 2.9876 USD. Today CO is up by 34.58%. In the past month the price increased by 34.58%. In the past year, price decreased by -35.19%.

CO Key Statistics

52-Week Range2.03 - 5.5
Current CO stock price positioned within its 52-week range.
1-Month Range2.16 - 3.32
Current CO stock price positioned within its 1-month range.
Market Cap
400.084M
P/E
5.15
Fwd P/E
N/A
EPS (TTM)
0.58
Dividend Yield
N/A

CO Stock Performance

Today
+34.58%
1 Week
+22.95%
1 Month
+34.58%
3 Months
-10.28%
Longer-term
6 Months -23.20%
1 Year -35.19%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

CO Stock Chart

Global Cord Blood Corporation / CO Daily stock chart

CO Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to CO. When comparing the yearly performance of all stocks, CO is a bad performer in the overall market: 68.4% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CO Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to CO. CO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CO Earnings

Next Earnings DateOct 11, 2022
Last Earnings DateJul 15, 2022
PeriodQ4 / 2022
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

CO Forecast & Estimates


Analysts
Analysts84.44
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

CO Groups

Sector & Classification

Index Membership

CO Financial Highlights

Over the last trailing twelve months CO reported a non-GAAP Earnings per Share(EPS) of 0.58. The EPS decreased by -1.41% compared to the year before.


Income Statements
Revenue(TTM)1.24B
Net Income(TTM)501.06M
Industry RankSector Rank
PM (TTM) 40.3%
ROA 5.87%
ROE 10.27%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-18%
Sales Q2Q%-1.69%
EPS 1Y (TTM)-1.41%
Revenue 1Y (TTM)7.21%

CO Ownership

Ownership
Inst Owners0.03%
Shares133.91M
Float38.40M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About CO

Company Profile

CO logo image Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. The company employs 1,202 full-time employees The company went IPO on 2009-11-19. The firm and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. The company provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. The company also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The firm provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. The company also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.

Company Info

IPO: 2009-11-19

Global Cord Blood Corporation

48 Fl., Bank Of China Tower

HK

CEO: Ting Zheng

Employees: 1202

CO Company Website

Phone: 85236058180.0

Global Cord Blood Corporation / CO FAQ

What does Global Cord Blood Corporation do?

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. The company employs 1,202 full-time employees The company went IPO on 2009-11-19. The firm and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. The company provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. The company also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The firm provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. The company also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.


Can you provide the latest stock price for Global Cord Blood Corporation?

The current stock price of CO is 2.9876 USD. The price increased by 34.58% in the last trading session.


Does CO stock pay dividends?

CO does not pay a dividend.


How is the ChartMill rating for Global Cord Blood Corporation?

CO has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


On which exchange is CO stock listed?

CO stock is listed on the New York Stock Exchange exchange.


What is the Price/Earnings (PE) ratio of Global Cord Blood Corporation (CO)?

The PE ratio for Global Cord Blood Corporation (CO) is 5.15. This is based on the reported non-GAAP earnings per share of 0.58 and the current share price of 2.9876 USD.


Can you provide the market cap for Global Cord Blood Corporation?

Global Cord Blood Corporation (CO) has a market capitalization of 400.08M USD. This makes CO a Small Cap stock.